Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

In silico study suggests SARS-CoV-2 Omicron XBB.1.5 strain to be more infective than previous strains

In silico study suggests SARS-CoV-2 Omicron XBB.1.5 strain to be more infective than previous strains

Study shows that SARS-CoV-2 infection is associated with an increased risk for maternal morbidity and severe complications

Study shows that SARS-CoV-2 infection is associated with an increased risk for maternal morbidity and severe complications

Exploring the clinical impact of co-detections of other respiratory viruses in US children hospitalized for COVID-19

Exploring the clinical impact of co-detections of other respiratory viruses in US children hospitalized for COVID-19

What is the association between COVID-19, cardiovascular disease, and mortality?

What is the association between COVID-19, cardiovascular disease, and mortality?

Researchers evaluate retrospectively obtained health-related quality-of-life data from COVID-19 patients

Researchers evaluate retrospectively obtained health-related quality-of-life data from COVID-19 patients

Researchers estimate COVID-19 Omicron variant mortality in Denmark

Researchers estimate COVID-19 Omicron variant mortality in Denmark

What was the prevalence of adverse events following first and second dose COVID-19 vaccinations in England?

What was the prevalence of adverse events following first and second dose COVID-19 vaccinations in England?

Bivalent BA.4-5 or BA.1 mRNA-booster given as a fourth dose associated with increased protection against COVID-19 hospitalization and death

Bivalent BA.4-5 or BA.1 mRNA-booster given as a fourth dose associated with increased protection against COVID-19 hospitalization and death

Study suggests Alzheimer’s disease diagnosis is associated with higher levels of soluble ACE2 in the human brain

Study suggests Alzheimer’s disease diagnosis is associated with higher levels of soluble ACE2 in the human brain

SARS-CoV-2 Omicron XBB.1.5, CA.3.1, and CH.1.1 exhibit remarkable antibody resistance

SARS-CoV-2 Omicron XBB.1.5, CA.3.1, and CH.1.1 exhibit remarkable antibody resistance

Heart symptoms persist in 10% of patients with long-COVID

Heart symptoms persist in 10% of patients with long-COVID

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

Senolytics could be a beneficial therapeutic for COVID neuropathology

Senolytics could be a beneficial therapeutic for COVID neuropathology

Borrowing from weather and climate science models can help us prepare for future pandemics

Borrowing from weather and climate science models can help us prepare for future pandemics

First known epidemic of highly pathogenic avian influenza H5N1 in farmed mink

First known epidemic of highly pathogenic avian influenza H5N1 in farmed mink

Analysis of seemingly recovered COVID-19 patients indicates that SARS-CoV-2 infection can persist significantly longer than suggested by PCR-negative tests

Analysis of seemingly recovered COVID-19 patients indicates that SARS-CoV-2 infection can persist significantly longer than suggested by PCR-negative tests

Longitudinal assessment of immunoglobulin G antibody responses to messenger ribonucleic acid vaccination doses and breakthrough infections

Longitudinal assessment of immunoglobulin G antibody responses to messenger ribonucleic acid vaccination doses and breakthrough infections

How effective are prior SARS-CoV-2 infections and hybrid immunity against Omicron breakthrough infections?

How effective are prior SARS-CoV-2 infections and hybrid immunity against Omicron breakthrough infections?

New trial evaluates Omicron BA.1–adapted BNT162b2 vaccine in older adults

New trial evaluates Omicron BA.1–adapted BNT162b2 vaccine in older adults

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.